Video Below: Prescription Osteoporosis Drugs May Be Doing Harm
Written by Keith D. Bishop, Clinical Nutritionist, B.Sc. Pharmacy
March 10, 2010
Studies show popular osteoporosis medications may weaken bones in the legs.
Researchers from Columbia University Medical Center studied 111 post-menopausal women taking bisphosphonates.
Bisphosphonates inhibit the normal digestion (breakdown) of bone by osteoclasts. Researchers found patients may
begin to experience weakening of their bones after only 4 years of use.
Bisphosphonates sold in the U.S. include Alendronate (Fosamax), Ibandronate (Boniva), Risedronate (Actonel) and
Zoledronate (Zometa, Aclasta). They are prescribed for treatment of osteopenia and osteoporosis.
It’s appears that long term bisphosphonates use may cause over
suppression of bone digestion for some women. Small cracks in the bone are unable to heal and connect together
and grow, resulting in unusual fractures. These fractures tend to heal poorly and often require bone surgery,
pins and grafting.
Reference Source: American Academy of Orthopedic Surgeons’ Annual Meeting in New Orleans, March
Natural Care Pearl The bisphosphonate side effect list continues to grow. If you are
interested in natural bone support, contact our office for our effective Bone Building Program. We try to find the
cause of your bone loss.
One client has seen her bone density improve over 3.5% in the past two years. She is not taking prescription
One requirement for our Bone Builder Program, you must get a 25-hydroxyvitamin D3 blood test from your doctor or
Vascular Disease Lab.
Interested attending a Bone Building Seminar in Oklahoma City.